Marine Derived Proteins Market Size & Share 2026-2035

Marine Derived Proteins Market Size

The global marine derived proteins market was valued at USD 9.1 billion in 2025. The market is expected to grow from USD 10 billion in 2026 to USD 22.3 billion in 2035, at a CAGR of 9.4% according to latest report published by Global Market Insights Inc.

The category spans bulk fishmeal and fish oil used in aquafeed as well as higher-value concentrates, hydrolysates, collagen peptides, gelatin, and specialized marine bioactives used in food, supplements, therapeutics, and cosmetics.

Marine raw materials offer commercial differentiation when their protein fractions are paired with marine lipids or deployed in applications requiring a defined amino-acid profile, peptide functionality, or collagen format. Fish species evaluated in the Western Indian Ocean have high essential-amino-acid contributions, while bivalve production supplies both complete protein and long-chain omega-3 fatty acids. ^{[1]MDPI, mdpi.com} Seaweed proteins can complement other ingredients in blended formulations, although protein quality and contaminant control remain highly dependent on species, processing, and cultivation conditions.

Supply conditions remain consequential because industrial fishmeal and fish oil output is exposed to fishery-management decisions and climate events. Peru's disrupted anchoveta season drove a sharp decline in fishmeal output during 2023, followed by a recovery in 2024 as landings improved; China absorbed a substantial portion of the rebound in Peruvian exports. ^{[2]Food and Agriculture Organization of the United Nations, fao.org} Over the longer term, OECD-FAO expects a rising proportion of fishmeal and fish oil to originate from processing by-products and trimmings, which can reduce dependence on whole-fish inputs but does not eliminate catch-related volatility.

The principal strategic tension is therefore not simply marine versus alternative protein. It is the need to preserve raw-material flexibility while maintaining application-specific consistency. Suppliers able to convert processing side streams into standardized ingredients can improve yield economics and resilience; suppliers relying on undifferentiated wild-catch inputs remain more exposed to quota changes, landing variability, and price transmission through the aquafeed chain.

Key Drivers

Nutritional positioning and formulation functionality

Marine proteins provide a route to combine protein fortification with omega-3, collagen, and bioactive-peptide positioning. Bivalves are particularly relevant to food and supplement formulators because their output can provide essential amino acids and EPA+DHA in the same raw-material stream. In algae-based ingredients, blending and processing determine whether amino-acid limitations are mitigated sufficiently for broader food applications. This makes ingredient selection a formulation decision rather than a generic protein substitution exercise.

Sports, recovery, and healthy-aging applications

Marine hydrolysates and collagen peptides are being developed for applications where bulk protein is not the only purchasing criterion. Research on marine-derived peptides identifies potential links to recovery, glucose handling, and inflammatory pathways, although product claims need to remain proportionate to the underlying clinical evidence. ^{[3]Frontiers, frontiersin.org} EPA and DHA have also been evaluated in athletic populations for recovery-related outcomes. Gelita introduced PeptEndure in late 2023 for endurance-oriented sports nutrition, illustrating how ingredient suppliers are translating peptide research into application-specific formats.

Cosmetics, healthcare demand, and digital access

Marine collagen and algae-derived actives benefit from the convergence of ingestible beauty, topical skin care, and premium supplement demand. Fish-derived collagen peptides have been evaluated in a clinical study of skin elasticity and wrinkle volume, creating a stronger basis for premium product positioning than a source-only claim. In parallel, online health-and-wellness platforms are expanding cross-border access to premium supplements; iHerb reported more than USD 2.4 billion in 2024 sales across 180 countries. The commercial effect is most visible for branded consumer products, while bulk ingredients remain predominantly sold through direct technical-sales relationships.

Driver & Restraint CAGR Impact

Key Restraints

Contaminants, traceability, and qualification costs

Marine environments can concentrate chemical contaminants, persistent pollutants, and emerging substances, making analytical testing and origin documentation core commercial requirements rather than back-office compliance tasks. ^{[4]ScienceDirect, sciencedirect.com} The exposure profile differs materially among finfish, shellfish, and macroalgae. Seaweed ingredients, for example, require species- and origin-specific controls for arsenic, cadmium, lead, mercury, and iodine.

The European Union's maximum-contaminant regulation establishes enforceable limits for several contaminants in food, while its mercury-monitoring recommendation covers fish, crustaceans, and molluscs. These requirements create an advantage for suppliers with validated supply chains and batch-level records, but they lengthen qualification cycles and raise testing costs for smaller processors. The restraint is especially significant in pharmaceutical, infant-nutrition, and premium-supplement applications, where a failed contaminant specification can disqualify an otherwise functional ingredient.

This dynamic separates high-value hydrolysates, collagen peptides, and specialty oils from commodity marine meals. In the former, evidence and qualification can support premium pricing; in the latter, catch cycles and aquafeed demand more directly govern margins. The most resilient portfolios combine both: volume-based outlets for raw-material utilization and specialized fractions that can absorb the cost of advanced processing and validation.

Marine Derived Proteins Market Segment Analysis

By Source

Fish-based

Fish-based proteins are projected to increase from USD 4,613.7 million in 2022 to USD 14,988.9 million by 2035, at an approximately 9.3% CAGR. Anchoveta, herring, mackerel, and other pelagic inputs support fishmeal and fish oil production, while salmon, cod, tuna, and whitefish side streams support collagen, gelatin, and hydrolysates. The segment's scale is its advantage, but Peru's 2023-2024 production swing demonstrates why processors are increasing use of trimmings and diversifying raw-material origins.

Shellfish-based

Shellfish-based proteins are expected to rise from USD 1,017.7 million in 2022 to USD 3,173.5 million by 2035, at approximately 8.9% CAGR. Shrimp, crab, mussel, oyster, and clam side streams offer opportunities for hydrolysates and functional peptide fractions. Bivalve aquaculture has expanded its contribution to protein and long-chain omega-3 supply, but shellfish sourcing requires heightened control of site-specific contaminants and biotoxins.

Algae-based

Algae-based proteins are projected to expand from USD 678.5 million in 2022 to USD 2,399.8 million by 2035, at an approximately 10.0% CAGR. Spirulina, chlorella, and cultivated macroalgae serve food, supplement, and personal-care applications where non-animal positioning, color, and co-occurring bioactives can matter alongside protein content. Their commercial constraint is not only protein extraction yield; it is achieving neutral sensory performance and maintaining contaminant specifications across cultivation sites.

Other

Other marine sources, including krill, sea cucumber, jellyfish, and marine microorganisms, are expected to increase from USD 474.9 million in 2022 to USD 1,731.0 million by 2035, at approximately 10.2% CAGR. These materials are generally positioned in specialized nutraceutical, cosmetic, and biomedical applications rather than as large-scale replacements for fishmeal. Their value proposition rests on distinctive peptide, lipid, or collagen fractions, which makes production control and application evidence central to commercialization.

By Product Type

Protein Concentrates & Isolates

Protein Concentrates & Isolates are the largest product segment, increasing from USD 2,849.7 million in 2022 to USD 9,533.6 million by 2035 and accounting for approximately 42.2% of 2025 revenue. The category includes fish protein concentrates, fish protein isolates, and seaweed protein concentrate. It benefits from broad food and feed applicability, although purity, sensory profile, solubility, and lipid retention create different value propositions across applications.

Protein Hydrolysates & Bioactive Peptides

Protein Hydrolysates & Bioactive Peptides are projected to grow from USD 1,628.4 million in 2022 to USD 5,418.6 million by 2035, representing approximately 24.1% of 2025 revenue. Enzymatic hydrolysates, acid/alkali hydrolysates, and enriched bioactive peptide fractions address distinct end uses. Enzymatic routes are more suited to applications requiring defined molecular-weight distributions and retained peptide functionality, while acid/alkali routes are more relevant to high-volume feed and industrial uses. Hofseth BioCare positions ProGo as a salmon protein hydrolysate for human and pet health applications, supported by a broader clinical-development program. ^{[5]Euronext, euronext.com}

Collagen & Gelatin

Collagen & Gelatin are forecast to rise from USD 1,357.0 million in 2022 to USD 4,407.5 million by 2035 at an approximately 9.3% CAGR, accounting for about 19.9% of 2025 revenue. Marine collagen, fish gelatin, and hydrolyzed collagen peptides benefit from the use of fish skins, scales, and bones that might otherwise be underutilized. Fish-derived collagen peptides have clinical support in skin-focused applications, while fish gelatin can meet formulation needs in halal and kosher-oriented product development.

Fishmeal & Fish Oil

Fishmeal & Fish Oil are expected to expand from USD 678.5 million in 2022 to USD 2,195.2 million by 2035, at approximately 9.2% CAGR. The category provides the volume base for marine-derived proteins, with aquaculture remaining its critical outlet. OECD-FAO projects continuing growth in aquaculture output and a rising contribution from processing waste to fishmeal and fish oil supply. The commercial challenge is balancing feed-performance requirements against the cost and availability of marine ingredients.

Functional Marine Compounds

Functional Marine Compounds are projected to increase from USD 271.4 million in 2022 to USD 738.3 million by 2035, at an approximately 7.8% CAGR. This segment includes fucoidans, carrageenans, astaxanthin-associated fractions, fucoxanthin, and specialized lipid-protein matrices. Its lower growth rate reflects the regulatory, clinical, and scale-up burden faced by novel bioactives, despite their potential use in cosmetics, functional foods, and pharmaceutical formulations.

By Distribution Channel

Direct Sales (B2B)

Direct Sales (B2B) are projected to rise from USD 3,799.5 million in 2022 to USD 12,433.1 million by 2035 and account for approximately 55.9% of 2025 revenue. Aquafeed producers, food manufacturers, pharmaceutical developers, and contract manufacturers often require batch-specific documentation on protein content, oxidation, microbiology, contaminants, and origin. Direct supply contracts therefore remain the practical route for complex ingredients and high-volume applications.

Distributors

Distributors are expected to increase from USD 2,578.3 million in 2022 to USD 8,505.5 million by 2035, representing approximately 38.0% of 2025 revenue. Their role is strongest for regional food manufacturers, smaller supplement brands, and mid-sized feed operators that need access to multiple suppliers without directly managing international sourcing and customs processes.

Online Channels

Online Channels are forecast to grow from USD 407.1 million in 2022 to USD 1,354.6 million by 2035 and account for approximately 6.0% of 2025 revenue. The channel is most relevant to finished collagen, omega-3, and sports-nutrition products rather than bulk ingredient transactions. Digital platforms facilitate customer education, subscription models, and dissemination of third-party testing information, but they also increase scrutiny of claims and source transparency.

By Application

Food & Beverages

Food & Beverages are projected to increase from USD 2,035.5 million in 2022 to USD 6,777.1 million by 2035, at an approximately 9.5% CAGR and about 30.1% of 2025 revenue. Authorized subsegments include functional foods, protein-fortified beverages, meat and seafood products, bakery and confectionery, dairy and dairy alternatives, and other food and beverage applications. Neutral flavor, dispersibility, and label compatibility determine whether fish and algae proteins can move from niche formulations into repeatable food manufacturing.

Dietary Supplements & Nutraceuticals

Dietary Supplements & Nutraceuticals are expected to rise from USD 1,764.1 million in 2022 to USD 5,729.4 million by 2035, at approximately 9.3% CAGR and 25.9% of 2025 revenue. Omega-3 supplements, collagen supplements, joint and bone health products, weight-management products, and other nutraceutical formats comprise the segment. Clinical evidence, dose format, and purity documentation influence purchasing more strongly than raw protein content in this channel.

Pharmaceuticals & Therapeutics

Pharmaceuticals & Therapeutics are forecast to grow from USD 949.9 million in 2022 to USD 3,165.6 million by 2035, at approximately 9.5% CAGR. The segment requires the most rigorous evidence, process validation, and regulatory discipline. Marine collagen peptides have been investigated in patients with type 2 diabetes, while specialized salmon-derived ingredients are being developed for medical and therapeutic applications. These uses offer high potential value but require far longer development and qualification timelines than food applications.

Cosmetics & Personal Care

Cosmetics & Personal Care are projected to rise from USD 746.3 million in 2022 to USD 2,385.4 million by 2035, at approximately 9.1% CAGR and 10.9% of 2025 revenue. Anti-aging products, skin hydration and elasticity products, hair and nail care, and other personal-care applications are included. Marine collagen peptides and algae-derived actives can support both ingestible and topical positioning, but European cosmetics requirements require safety substantiation and compliant ingredient documentation.

Aquaculture & Animal Feed

Aquaculture & Animal Feed are expected to increase from USD 882.0 million in 2022 to USD 2,942.7 million by 2035, at an approximately 9.5% CAGR and 13.0% of 2025 revenue. Feed demand provides a major volume outlet for fishmeal and fish oil, but feed formulators are increasingly incorporating trimmings, alternative proteins, and novel oils to manage cost and supply exposure. Cargill reported that 34.5% of its marine ingredients were derived from fish trimmings in 2024, illustrating the strategic move toward circular sourcing. ^{[6]Cargill, cargill.com}

Sports Nutrition

Sports Nutrition is forecast to rise from USD 339.2 million in 2022 to USD 1,047.8 million by 2035, at approximately 8.9% CAGR and 4.9% of 2025 revenue. Protein powders and bars, recovery supplements, and performance nutrition products are the principal subsegments. Marine collagen and peptide fractions are differentiated by connective-tissue and recovery positioning, whereas omega-3 ingredients extend the category beyond conventional protein supplementation.

Others

Other applications, including industrial biotechnology and agricultural uses, are expected to increase from USD 67.8 million in 2022 to USD 245.2 million by 2035. These uses can improve utilization of low-value side streams but remain comparatively small and sensitive to local processing economics.

The channel and application mix reinforces this distinction. Direct B2B sales dominate where technical specifications and qualification are decisive, while online channels act as a commercialization indicator for branded collagen and omega-3 formats. Aquafeed anchors demand for marine meals and oils, but premium growth is more likely to accrue to suppliers that can convert marine side streams into documented, differentiated fractions for food, therapeutic, and beauty applications.

Marine Derived Proteins Market Regional Analysis

North America

North America is projected to increase from USD 2,306.9 million in 2022 to USD 7,535.1 million by 2035, at an approximately 9.3% CAGR. The U.S. is the dominant country market, expected to rise from USD 1,845.5 million to USD 6,028.1 million. The region combines mature supplement retail, direct-to-consumer infrastructure, and established aquaculture and pet-food demand. Omega Protein's U.S. menhaden operations provide a domestic production base for fishmeal, fish oil, and fish solubles. ^{[7]Omega Protein Corporation, omegaprotein.com} Canada contributes through supplements, food ingredients, and premium natural-health-product channels.

Europe

Europe is forecast to grow from USD 1,967.6 million in 2022 to USD 6,509.6 million by 2035, at approximately 9.4% CAGR. Germany, the UK, France, Spain, Italy, and Rest of Europe are covered. European demand is shaped by food-safety controls, sustainability qualifications, and mature collagen, omega-3, and cosmetics markets. Denmark is an important industrial supply base through companies such as FF Skagen A/S, while Germany supports high-value collagen and nutraceutical activity. EU contaminant regulations create compliance costs but can also protect qualified suppliers from lower-documentation imports. ^{[8]EUR-Lex, eur-lex.europa.eu}

Asia Pacific

Asia Pacific is expected to record the fastest regional growth, increasing from USD 1,899.8 million in 2022 to USD 6,487.3 million by 2035 at an approximately 9.7% CAGR. China, India, Japan, Australia, South Korea, and Rest of Asia Pacific are included. China's role as a major aquaculture producer and fishmeal importer makes it central to both industrial demand and raw-material trade. India's developing supplement market and Japan's established premium health-and-wellness consumption create contrasting opportunities: India offers volume growth, while Japan supports specialized collagen and DHA formats. Australia and South Korea remain innovation-oriented markets for beauty-from-within and sports-nutrition products.

Latin America

Latin America is projected to rise from USD 407.1 million in 2022 to USD 1,293.0 million by 2035, at an approximately 9.1% CAGR. Brazil, Mexico, Argentina, and Rest of Latin America are included. Peru is regionally significant because its anchoveta landings influence global fishmeal and fish oil availability; the 2024 rebound in output demonstrates how quickly regional fishery conditions can affect global ingredient trade. PESQUERA DIAMANTE's processing network illustrates Peru's capacity to connect capture fisheries with global feed and ingredient buyers. Brazil contributes growing aquaculture demand and a developing domestic market for functional nutrition products.

Middle East & Africa

The Middle East & Africa market is expected to increase from USD 203.5 million in 2022 to USD 468.2 million by 2035, at an approximately 6.3% CAGR. Saudi Arabia, South Africa, the UAE, and Rest of Middle East and Africa are covered. Demand is concentrated in Gulf retail, pharmacy, and premium wellness channels, while South Africa remains an important distribution gateway for sub-Saharan markets. Growth is slower than the global average because large-scale aquaculture-feed demand, domestic specialty processing, and mature nutraceutical regulations are less developed than in North America, Europe, and Asia Pacific.

Latin America's role is strategically larger than its market value alone suggests. Peruvian anchoveta output affects global availability and pricing for fishmeal and fish oil, so disruptions can transmit through feed and specialty-ingredient supply chains well beyond the region. The Middle East & Africa offers selective premium opportunities, but its slower trajectory reflects structural limits in local processing capacity and downstream market development rather than a lack of product relevance.

Marine Derived Proteins Market Share & Competitive Landscape

The market is moderately concentrated. PESQUERA DIAMANTE holds an estimated 9.7% share of 2025 revenue, followed by Cargill at approximately 8.8%, FF Skagen A/S at 7.4%, Prima Protein AS at 6.6%, and Omega Protein Corporation at 5.2%. Competition differs markedly by product type: large processors compete on raw-material access, yield, certification, and logistics, while specialty suppliers compete through formulation, clinical evidence, purification capability, and application support.

Cargill

Cargill operates across aquaculture nutrition and is positioned around feed formulation, marine-ingredient sourcing, and alternative-input development. Its 2024 reporting identified certified or sustainable sources for 84% of marine ingredients and a rising contribution from fish trimmings, reducing dependence on forage-fish inputs. This strategy is commercially relevant because feed customers need both performance consistency and lower exposure to volatile marine raw-material supply.

Epax

Epax supplies concentrated marine omega-3 ingredients for pharmaceutical, supplement, and infant-nutrition applications. Its portfolio includes EPA/DHA concentrates in multiple delivery forms and concentrations, positioning the company in high-specification channels where purity, oxidation control, and regulatory readiness affect supplier selection. ^{[9]Epax, epax.com}

FF Skagen A/S

FF Skagen A/S is a Danish fishmeal and fish oil producer with processing capacity and export reach suited to global aquafeed customers. The company reports approximately 500,000 tonnes of annual raw-material processing capacity and production of about 170,000 tonnes of fishmeal and fish oil, supported by international sales. Its competitive position depends on documented sourcing and certification as much as processing scale.

Hofseth BioCare

Hofseth BioCare upcycles Norwegian salmon side streams into ProGo protein hydrolysate, OmeGo salmon oil, and CalGo/NT-II bone and joint-health ingredients. The company's development strategy centers on branded fractions and clinical programs rather than commodity salmon by-products. Its 2024 annual reporting described continued expansion plans, including a second hydrolysis plant project in Berkak.

Omega Protein Corporation

Omega Protein Corporation operates an integrated U.S. menhaden supply chain, including vessels, processing facilities, fishmeal, fish oil, and fish-solubles production. Its domestic infrastructure and fisheries certifications support supply assurance for aquafeed, pet-food, and omega-3 markets.

Recent Industry Developments

• Q4 2024 - Hofseth BioCare initiated a project for a second hydrolysis plant in Berkak, Norway, to expand salmon protein hydrolysate capacity.
• October 2024 - FF Skagen A/S received MarinTrust Improvement Program acceptance for Blue Whiting sourcing in the Northeast Atlantic, supporting continuity of supply to certification-sensitive aquafeed buyers.
• September/October 2024 - PESQUERA DIAMANTE's Callao facility was certified to the MarinTrust Global Standard for Responsible Supply version 3.0.